Roche just heralded a great set of placebo comparisons for their new flu drug — too bad it flopped against generic Tamiflu
Genentech just rolled out some of the hard data around its Phase III CAPSTONE-2 trial for their new flu medicine baloxavir marboxil, and it doesn …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
